A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma

Bibliographic Details
Title: A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma
Authors: Anshun Wu, Fayin Liu, Lei Zhou, Runyi Jiang, Shangjiang Yu, Zihuan Zhou, Qi Zhang, Qian Zhang, Dongjie Jiang, Shaohui He, Haifeng Wei
Source: Discover Oncology, Vol 15, Iss 1, Pp 1-15 (2024)
Publisher Information: Springer, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Ewing sarcoma, Histone acetylation, HDAC2, Prognostic signature, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Histone acetylation is an important epigenetic modification, modulating the development of many tumors. However, the functions of most histone acetylation-related genes (HARGs) and their prognostic values in Ewing sarcoma (EWS) remain unclear. The current study aimed to investigate the prognostic values and potential functions of HARGs in EWS. After collecting EWS patients with mRNA sequencing data from the Gene Expression Omnibus (GEO) database and a list of HARGs from previous studies, Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) regression were performed to construct a prognostic gene signature based on HARGs. Then, four HARGs (TAF4, ATF2, HDAC2 and OGA) composed a formula to calculate risk score for each patient in the training cohort. Based on median risk score, all patients were classified into low- and high-risk group, and patients with high-risk score had a poor survival outcome (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2730-6011
Relation: https://doaj.org/toc/2730-6011
DOI: 10.1007/s12672-024-01689-4
Access URL: https://doaj.org/article/0afeb7e6a2624e538cef9b91f6ed1f94
Accession Number: edsdoj.0afeb7e6a2624e538cef9b91f6ed1f94
Database: Directory of Open Access Journals
More Details
ISSN:27306011
DOI:10.1007/s12672-024-01689-4
Published in:Discover Oncology
Language:English